LM

Lenard Marcus

General Partner

Princeton, New Jersey

Overview 

Lenard Marcus is currently a General Partner at Edison Partners in Princeton, New Jersey, with a focus on investing in Seed and Pre-seed stages in sectors such as Enterprise, Health IT, and SaaS. With an MBA from Columbia Business School and experience serving on the boards of companies like Capital Rx, NS8 Inc, and Bricata, Lenard has successfully invested in notable companies like Get Spiffy and SPHERE, showcasing a strong track record in venture capital and strategic leadership.

Work Experience 

CR

Capital Rx

  • Board Member

    2019 - Current

Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.

Raised $252,960,628.00 from Prime Therapeutics.

cap-rx.com
NI

NS8 Inc

  • Board Member

    2019

NS8 is a fraud prevention platform that combines behavioral analytics and real-time scoring to help businesses minimize risk.

Raised $157,875,000.00 from Sorenson Ventures, Edison Partners, Lightspeed Venture Partners and AXA Venture Partners.

ns8.com
B

Bricata

  • Board Member

    2017

    Open source intrusion prevention and detection platform based on the union of the Zeke (Bro) and Suricata engines.

V

VirtualHealth

  • Board Member

    2016

    Cloud native care management platform

Edison Partners

  • General Partner

    2004

e

eSentire

  • Board Member

    2013 - 2019

K

Kemp

  • Board Member

    2012 - 2019

Portico

  • Board Member

    2008 - 2011

Adjoined Consulting

  • Consultant

    2004 - 2004

    Provided financial analysis for asset management client to determine how to increase productivity of high net worth segment. Created case study for technical implementation of business rules engine for financial services client. Generated NPV and IRR analysis for client

Princeton eCom

  • Product Development Manager

    2000 - 2002

  • Product Development Manager

    2000 - 2002

Education 

Investments 

Get Spiffy

Series B

Total funding: $43M

Field Effect Software

Series A

Total funding: $65M

SPHERE

Series B

Total funding: $41M

Capital Rx

Series A

Total funding: $220M

Articles About Lenard

Relevant Websites